Pro-Dex Inc
Pro-Dex Inc maintains a relatively strong liquidity position, with a current ratio of 3.23, indicating the company can cover its short-term liabilities more than three times over with its current assets. However, the company's cash and equivalents amount to only $419,000, which is significantly lower than its long-term debt of $15,394,000, resulting in a negative net cash position. This suggests potential liquidity risk if short-term obligations exceed available cash. The company's profitability metrics are robust, with a return on equity (ROE) of 24.51% and a return on assets (ROA) of 14.67%. These figures exceed the typical thresholds for strong performance in the medical equipment and supplies industry, indicating efficient use of equity and assets to generate profit. The operating margin, calculated as operating income of $10,689,000 on revenue of $66,593,000, is approximately 16.05%, which is in line with industry expectations for firms of similar scale. Geographically and segment-wise, Pro-Dex Inc's revenue is not disclosed by region or business segment in the available data. However, the company's primary business activity is centered on medical equipment and supplies, which are typically less sensitive to geographic concentration risks compared to other healthcare subsectors. The absence of segment-specific data limits the ability to assess potential overreliance on a single product line or geographic market. Looking ahead, the company's growth trajectory appears stable, with no specific revenue growth rates provided in the input data. Analysts have assigned a mean price target of $70.00, with a median and high target also at $70.00, suggesting a consensus on the stock's fair value. The mean recommendation of 2.00 (on a scale from 1 to 5) indicates a "buy" rating, with one analyst recommending a "buy" and none recommending a "strong buy" or "strong sell". Risk factors for Pro-Dex Inc include its negative net cash position, which could limit flexibility in responding to market changes or capital needs. The company's liquidity risk is rated as medium, and while dilution risk is currently low, the absence of a significant equity cushion could expose the company to dilution pressure in the event of a capital raise. No specific dilution sources are disclosed in the input data, but the company's low dilution risk suggests that such events are not imminent. Recent events and disclosures for Pro-Dex Inc are not detailed in the input data. However, the company's financial performance and analyst ratings suggest a stable outlook, with no immediate signs of distress or volatility. The absence of recent filings or transcripts does not necessarily indicate a lack of activity, but it does limit the ability to assess the company's strategic direction or operational changes in the near term.
Business. Pro-Dex Inc provides medical equipment, supplies, and distribution services within the healthcare sector, primarily generating revenue through the sale and distribution of medical products and services.
Classification. Pro-Dex Inc is classified under the industry "Medical Equipment, Supplies & Distribution" within the Healthcare Services & Equipment business sector, with a classification confidence of 0.92.
- Pro-Dex Inc has a strong ROE of 24.51% and ROA of 14.67%, indicating efficient use of equity and assets to generate profit.
- The company's liquidity position is strong with a current ratio of 3.23, but its negative net cash position raises concerns about short-term flexibility.
- Analysts have assigned a mean price target of $70.00, with a "buy" recommendation, suggesting a positive outlook for the stock.
- The company's risk profile is moderate, with medium liquidity risk and low dilution risk.
- No segment or geographic revenue breakdown is available, limiting the ability to assess concentration risks.
- The company's capital structure is relatively balanced, with a debt-to-equity ratio of 0.42.
- --
- # RATIONALES
- Net cash is negative after subtracting total debt.